rs794727995
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP2PP3PP5_Very_Strong
The ENST00000241704.8(COPA):c.721G>A(p.Glu241Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E241A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000241704.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COPA | NM_004371.4 | c.721G>A | p.Glu241Lys | missense_variant | 9/33 | ENST00000241704.8 | NP_004362.2 | |
COPA | NM_001098398.2 | c.721G>A | p.Glu241Lys | missense_variant | 9/33 | NP_001091868.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COPA | ENST00000241704.8 | c.721G>A | p.Glu241Lys | missense_variant | 9/33 | 1 | NM_004371.4 | ENSP00000241704 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autoimmune interstitial lung disease-arthritis syndrome Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Sep 16, 2022 | ACMG classification criteria: PS3 supporting, PS4 supporting, PM2 moderated, PM6 moderated, PP1 strong, PP2 supporting, PP3 supporting - |
Pathogenic, criteria provided, single submitter | research | Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine | Apr 20, 2015 | Segregates with the phenotype in an affected family, in vitro functional studies. The family showed incomplete penetrance, with unaffected carriers over six generations. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 07, 2019 | For these reasons, this variant has been classified as Pathogenic. This variant has been reported to affect COPA protein function (PMID: 25894502). This variant has been observed to be de novo in an individual affected with autoimmune interstitial lung, joint, and kidney disease and segregates with disease in several families (PMID: 29137621, 25894502). ClinVar contains an entry for this variant (Variation ID: 199256) This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with lysine at codon 241 of the COPA protein (p.Glu241Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at